 |
The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
On July 25, 2013, from 2:00PM-3:00PM (EDT), FDA will present a webinar on a new draft guidance entitled "Draft Guidance for Industry on Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment; Availability."
The webinar will provide an opportunity to learn about the guidance from individuals involved in its preparation. It is also intended to encourage the submission of questions or comments while the guidance is still in draft form.
Questions may be submitted online during the webinar and will be addressed as time permits. All questions should also be submitted to docket so that they can be formally processed by FDA.
DRAFT GFI:
FR NOTICE
http://www.gpo.gov/fdsys/pkg/
For more information please visit: FDA HIV Webinar
For more information please visit: FDA HIV Webinar
No hay comentarios:
Publicar un comentario